Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
Roser Pinyol(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Joong‐Won Park(National Cancer Center), Agrin Moeini(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), L. Lupo, Han Chu Lee(Asan Medical Center), Daniela Sia(Icahn School of Medicine at Mount Sinai), Umberto Cillo(University of Padua), Robert Montal(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Jordi Camps(Centro de Investigación Biomédica en Red), Leonardo Rodríguez‐Carunchio(Hospital Clínic de Barcelona), Augusto Villanueva(NYU Langone Health), Vincenzo Mazzaferro(Fondazione IRCCS Istituto Nazionale dei Tumori), Manel Solé(Hospital Clínic de Barcelona), Jordi Bruix(Hospital Clínic de Barcelona), Laia Bassaganyas(Universitat Pompeu Fabra), Simone I. Strasser(University of Padua), Carol Peña(Bayer (United States)), Edward Gane(University of Auckland), Swan N. Thung(Icahn School of Medicine at Mount Sinai), Zhongyang Zhang(Icahn School of Medicine at Mount Sinai), Tadatoshi Takayama(Nihon University), Norihiro Kokudo(The Cancer Institute Hospital), Gar-Yang Chau(Taipei Veterans General Hospital), Adina Croitoru(Institutul Clinic Fundeni), Gerold Meinhardt(Daiichi Sankyo (United States)), Manuel de la Mata(Cedars-Sinai Medical Center), Chris Verslype(Universitair Ziekenhuis Leuven), Sasan Roayaie(White Plains Hospital), Sara Torrecilla(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas)
Cited by 338
Related Papers
Management of Hepatocellular Carcinoma: An Update Δσ
|Hepatology|2011|8.1k
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Management of Hepatocellular Carcinoma *
|Hepatology|2005|5.9k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k